In a cohort of early-stage AD subjects who were categorized into apolipoprotein E genotyping, an apolipoprotein E ɛ4 dose was associated with a decreased BBB water exchange rate, resulting in brain Aβ accumulations and cognitive disturbances (Uchida et al., 2022a). Here, APOE is linked to Alzheimer disease.